Erythropoiesis
New erythropoiesis study results from A.M. Newland et al described
Published in Medical Letter on the CDC and FDA, February 1st, 2009
According to recent research published in the journal Annals of Pharmacotherapy, "To evaluate, characterize, compare, and critique trials reporting increased tumor progression in patients with cancer who are receiving erythropoiesis-stimulating agents (ESAs) that led to Food and Drug Administration (FDA) actions for black box warnings and labeling changes. Literature was accessed through MEDLINE (1950-August 2008) and PubMed (1975-August 2008) using the search terms recombinant erythropoietin, darbepoetin, epoetin, anemia, neoplasms, and disease progression."
"Articles cited in MedWatch alerts, Oncologic Drugs Advisory Committee meeting briefs, and bibliographies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Alexion Pharmaceuticals, Inc.
Soliris Receives Orphan Drug Designation in Japan - Asthma
New asthma study findings reported from Daegu Haany University, Medical Department - Breast Cancer
Research from University of Pennsylvania in the area of breast cancer described - Drug Development
Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development - Heart Failure
Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium - Life Sciences
Study findings on life sciences are outlined in reports from George Mason University - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
